UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

The Exciting New Field of HER2-Low Breast Cancer Treatment

Cancers, 2021-03, Vol.13 (5), p.1015

2021

Link zum Volltext

Verfügbarkeit prüfen

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

BMC cancer, 2021-08, Vol.21 (1), p.1-9, Article 899

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience

Breast (Edinburgh), 2021-06, Vol.57, p.86-94

2021

Link zum Volltext

Verfügbarkeit prüfen

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer

Cancers, 2022-05, Vol.14 (11), p.2596

2022

Link zum Volltext

Verfügbarkeit prüfen

Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center

BMC palliative care, 2018-01, Vol.17 (1), p.13-13, Article 13

2018

Link zum Volltext

Verfügbarkeit prüfen

Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review

Anais brasileiros de dermatología, 2018-07, Vol.93 (4), p.553-558

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials

ESMO open, 2020-01, Vol.5 (1), p.e000659, Article e000659

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and real-world progression-free survival (rwPFS) of patients with HER2-positive and hormone receptor (HR)-positive metastatic breast cancer (MBC) initiating endocrine therapy (ET) in combination with the first line of treatment: An analysis of electronic health records in the United States

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13028-e13028

2022

Link zum Volltext

Verfügbarkeit prüfen

Sustained Viral Response to Ipilimumab Treatment in a Patient with HCV Chronic Infection and Metastatic Melanoma： A Case Report

Journal of pharmacy and pharmacology (El Monte), 2017-05, Vol.5 (5), p.231-236

Daniel Eiger Rodrigo Coutinho Mariano Patricia Taranto Daniela Pezzutti Domingues Armentano Rene Claudio Gansl

2017

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic Cancer with Normal CA 19-9 and Lewis Antigen Negative--Case Report

Journal of pharmacy and pharmacology (El Monte), 2017-03, Vol.5 (3), p.149-152

Rodrigo Coutinho Mariano Noam Fabel Ponde Daniel Eiger Patricia Taranto Vanderlei Segatelli Daniela Pezzutti Armentano Rene Claudio Gansl

2017

Link zum Volltext

Verfügbarkeit prüfen

Emerging Therapeutics for Patients with Triple-Negative Breast Cancer

Current oncology reports, 2021-05, Vol.23 (5), p.57-57, Article 57

2021

Link zum Volltext

Verfügbarkeit prüfen

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial

Journal of clinical oncology, 2022-09, Vol.40 (25), p.2946-2956

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials

European journal of cancer (1990), 2021-05, Vol.148, p.76-91

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.462-470

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of HIV infection on baseline characteristics and survival of women with breast cancer

AIDS (London), 2021-03, Vol.35 (4), p.605-618

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS7-21: Timelines to initiate an adjuvant phase III trial across the globe: A sub-analysis of the APHINITY trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS7-21-PS7-21

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-14-05: The impact of erythropoietin administration concomitantly with adjuvant anti-HER2 treatment on the patients’ outcome: Sub-analysis of the ALTTO study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-14-05

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Breast cancer research and treatment, 2024-02, Vol.203 (3), p.497-509

2024

Link zum Volltext

Verfügbarkeit prüfen

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors

Breast cancer research and treatment, 2020-05, Vol.181 (1), p.199-209

2020

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab in HER2-positive early breast cancer: current use and perspectives

Future oncology (London, England), 2019-06, Vol.15 (16), p.1823-1843

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-11-03: Characteristics and survival outcomes of HIV-positive breast cancer patients: A systematic review and meta-analysis

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-11-03

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study

British journal of cancer, 2022-11, Vol.127 (10), p.1799-1807

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC)

Acta oncologica, 2020-06, Vol.59 (6), p.723-725

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

British journal of cancer, 2020-05, Vol.122 (10), p.1453-1460

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Exciting New Field of HER2-Low Breast Cancer Treatment

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer

Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center

Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials

Sustained Viral Response to Ipilimumab Treatment in a Patient with HCV Chronic Infection and Metastatic Melanoma： A Case Report

Pancreatic Cancer with Normal CA 19-9 and Lewis Antigen Negative--Case Report

Emerging Therapeutics for Patients with Triple-Negative Breast Cancer

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial

Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials

Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

Impact of HIV infection on baseline characteristics and survival of women with breast cancer

Abstract PS7-21: Timelines to initiate an adjuvant phase III trial across the globe: A sub-analysis of the APHINITY trial

Abstract P1-14-05: The impact of erythropoietin administration concomitantly with adjuvant anti-HER2 treatment on the patients’ outcome: Sub-analysis of the ALTTO study

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors

Pertuzumab in HER2-positive early breast cancer: current use and perspectives

Abstract P6-11-03: Characteristics and survival outcomes of HIV-positive breast cancer patients: A systematic review and meta-analysis

Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC)

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

Suchergebnisse filtern